Entering text into the input field will update the search result below

T2 Biosystems cut to Neutral at BTIG on upcoming Q2 revenue miss, focus on cash burn

Jul. 07, 2022 9:38 AM ETT2 Biosystems, Inc. (TTOO) StockBy: Ravikash, SA News Editor

Flag and Wall street sign

Fabrice Cabaud

T2 Biosystems (NASDAQ:TTOO) was downgraded by BTIG Research to Neutral from Buy after the company placed its preliminary Q2 revenue numbers below consensus.

The SA Quant Rating on TTOO is Strong Sell, which takes into account factors such

Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

About TTOO

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
T2 Biosystems, Inc.
MAIA Biotechnology, Inc.
Oncotelic Therapeutics, Inc.
BioCardia, Inc.
Orgenesis Inc.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.